Changes to CPT Coding for 2015

Toxicology CPT Code Changes for 2016

Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G

The CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes.

January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several

Oral Fluid Drug Testing March 23 rd, 2015

Oral Fluid Drug Testing March 23 rd, 2015 Drug Testing Options Breath Blood Meconium Vitreous Hair Sweat Urine Oral Drug Testing Options Oral Fluid and Blood and Breath Actual levels (immediate use, up

Tests Impacted by 2015 CPT Changes

Toxicology Changes for 2015 HPV Examples of Toxicology Panels Molecular Pathology, FISH and Anatomic Pathology 1 Toxicology Changes for 2015 80100 Test Code Dos Test Name 2015 2015 Medicare 5229 Drug Screen,

Early Morning Waking Excessively Orderly or Perfectionistic

COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information

PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency

Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.

Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review

An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse

Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that

Drugs with Anticholinergic Activity

PL Detail-Document #271206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER December 2011 Drugs with Anticholinergic

Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,

DUI in Southern Ohio MATT 2006

DUI in Southern Ohio MATT 2006 Laureen J. Marinetti, M.S., Ph.D. Chief Toxicologist Montgomery County Coroner s s Office & Miami Valley Regional Crime Lab (MVRCL) Dayton, Ohio Region The MVRCL is a regional

12629 LIBRIUM CHLORDIAZEPOXIDE HCL 12637 LIBRIUM CHLORDIAZEPOXIDE HCL 12645 LIBRIUM CHLORDIAZEPOXIDE HCL 13110 VALIUM DIAZEPAM 13277 VALIUM DIAZEPAM 24406 LITHANE LITHIUM CARBONATE 25836 SURMONTIL TRIMIPRAMINE

Handout 2 List of medications used to treat mental illness

Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following

PSYCHIATRIC MEDICATION USE DURING PREGNANCY AND BREASTFEEDING

E-Resource May 2014 PSYCHIATRIC MEDICATION USE DURING PREGNANCY AND BREASTFEEDING Psychotropic medication use during pregnancy may have adverse effects, however, there is a growing body of evidence that

YOUR MEDICATIONS WHAT YOU SHOULD KNOW

YOUR MEDICATIONS WHAT YOU SHOULD KNOW A Handbook For People With Developmental Disabilities Developmental Disabilities Area Board 10 Developmental Disabilities Area Board 10 411 N. Central Avenue Suite

Psychiatric Evaluation Intake Form

Psychiatric Evaluation Intake Form 1. Patient Contact Information Patient Name Preferred Name Last First MI Address_ Best contact phone number: Email address: Primary Care Physician Tel Fax Pharmacy Phone

Updated MAR 26, 2013 Myelography Seizures:

Updated MAR 26, 2013 Myelography Medications to be evaluated prior to myelography. This list is to assist the radiologist, pharmacist, and radiology technologist in evaluating medication risk associated

PSYCHIATRY. Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #:

Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #: Primary Care Physician: Current Therapist/Counselor: How did you hear about us? Internet Insurance Other Providers (specialty):

CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003

Page 1 ATTACHMENT C CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003 PURPOSE This policy provides guidelines for the detection and deterrence of alcohol and drug

Mental Health Medications

Mental Health Medications National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Contents Mental Health Medications..............................................................1

SMART DISCHARGE. Client s Name: Client ID: Partial Hospitalization Clinically Managed Medium Intensity Residential Treatment

SMART DISCHARGE Client s Name: Client ID: DATE OF DISCHARGE: Reason for Discharge Completed Treatment no further treatment needed Completed Treatment Plan/Referred Incomplete Client Left Before Completing

A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES

INTRODUCTION A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES Individuals with intellectual disabilities are not uncommonly prescribed psychotropic medications.

Medications A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications.

A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications. 2014 Contents Introduction: Mental Health Medications...1 What are

Medications Used in the Management of Disruptive Behavior Disorders

The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.

PSYCHIATRIC MEDICATIONS AND HIV ANTIRETROVIRALS ADULT MANAGEMENT Winter 2013 ADRUGINTERACTIONGUIDEFORCLINICIANS

PSYCHIATRIC MEDICATIONS AND HIV ANTIRETROVIRALS ADULT MANAGEMENT Winter 2013 ADRUGINTERACTIONGUIDEFORCLINICIANS Psychiatric Medications and HIV Antiretrovirals: A Drug Interaction Guide for Clinicians

Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014

Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014 The Arizona Department of Health Services, Division of Behavioral Health Services,

2015 CPT Code Changes ACL Test

Changes ACL Test Test Description UCOMP DRUG SCREEN COMPLETE 80100 80303 G0431 UDINV DRUG INVESTIGATION 80100 80303 G0431 UTLC THIN LAYER CHROMATOGRAPHY DRUG SCREEN 80100 80303 G0431 UNIC NICOTINE, URINE

Neurotransmitters Made Easy: The Mood Teeter-Totter

Neurotransmitters Made Easy: The Mood Brad Lander PhD, LICDC Clinical Director / Psychologist Talbot Hall - Addiction Medicine at The Ohio State University Wexner Medical Center Key Point #1 Thinking and

Antipsychotics and the Nursing Home

Antipsychotics and the Nursing Home Lisa M. O Hara, PharmD, CGP Corporate Director of Clinical Services The State Operations Manual Part 1: F329 Unnecessary Drugs Medication Management Defined Helps promote

Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates. Patient History Form

Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates Patient History Form Name Date Age DOB SSN Address City State ZIP Patient s Telephone (H) (W) (Cell) Email Job Title or School

EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302

New Patient Packet 03/10/2015 EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302 Thank you for allowing us to assist in your care. We look forward to meeting you.

Phone (Home) Phone (Work or other) Primary Care Physician: PCP Address: Phone: Referring Physician (if different than PCP):

Addressograph or Patient Name and Medical Record Number Clinics Pain Mngmt New Patient Health Questionnaire Patient Name: Last First Middle Maiden Address: Street City State Zip Phone (Home) Phone (Work

University of Florida & Shands Adult Psychiatry Outpatient Clinic Intake Form

University of Florida & Shands Adult Psychiatry Outpatient Clinic Intake Form Date Name Age Address Home phone Work phone Cell phone What issue(s) bring(s) you to the Psychiatry Clinic? What has been stressing

Medication Management Improvement System

Medication Management Improvement System Protocol #3: Falls and Dizziness Related to the Use of Central Nervous System-Active Medications Problem: Goal: Use of medications that increase risk of falls and

Why is medication recommended as part of the treatment for mental illness?

Medications for Psychiatric Disorders Introduction This article discusses medications for psychiatric disorders. Information is provided about the effects of medications, including their advantages and

PtProtect Pain Medication Management Program Monitors Patient Compliance

PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve

PRESCRIPTION DRUG ABUSE

PRESCRIPTION DRUG ABUSE Carl M. Dawson, M.S., MAC, LPC - National Drug Court Institute ( NDCI ) Washington, D. C. - The School of Professional Psychology at Forest Institute Springfield, Missouri ( cdawson1028@yahoo.com

What Does the Drug Test Tell Us

What Does the Drug Test Tell Us QUALITATIVE TOXICOLOGY TESTING for CLINICAL MANAGEMENT of the PATIENT Background The qualitative drug test is often referred to as the drug screen - a misnomer Testing performed

Pain Medication Management Program Monitors Patient Compliance

PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

Understanding Drug Screens & PharmCAS Drug Screening Program Overview. Suzi Arant, Senior Business Developer July 8, 2011

Understanding Drug Screens & PharmCAS Drug Screening Program Overview Suzi Arant, Senior Business Developer July 8, 2011 Presentation Overview Drug Screening in Healthcare Drug Screening Panels Drugs of

June 2016 Updated Crosswalk:

June 2016 Updated Crosswalk: 2016 HCPCS G0279 G6001 G6002 G6003 G6004 deleted f Radiology Coding BCBSNC currently considers this service investigational and will not cover either the HCPCS CPT s. Diagnostic

Medications for Huntington s Disease Vicki Wheelock, M.D.

Medications for Huntington s Disease Vicki Wheelock, M.D. Director, HDSA Center of Excellence at UC Davis June 4, 2013 Outline Introduction and disclaimers Medications for cognitive symptoms Medications

Urine Drug Toxicology and Pain Management Testing. Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA

Urine Drug Toxicology and Pain Management Testing Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA Learning Objectives Describe what chronic pain is, who is affected and

Oral Fluid as an alternative matrix in workplace drug testing: which drugs at which cutoff concentration?

Oral Fluid as an alternative matrix in workplace drug testing: which drugs at which cutoff concentration? Michael Böttcher MVZ Labor Dessau Gmb, Dessau, Germany a d d i c t i o n / a b u s e r e l e v

Generic and Brand Drug Names Purpose Usual Dose and Frequency Potential Side Effects Emergency Conditions Cautions Addiction Treatment Medications

Generic and Brand Drug Names Purpose Usual Dose and Frequency Potential Side Effects Emergency Conditions Cautions Addiction Treatment Medications Published in 2000 by the Mid-America Addiction Technology

Drug Class Review Drugs for Fibromyalgia

Drug Class Review Drugs for Fibromyalgia Final Original Report April 2011 The Agency for Healthcare Research and Quality has not yet seen or approved this report. The purpose of the is to summarize key

2013 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS

Toxicology Program Trends 213 213 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS Overview and Background This report discusses trends in the toxicology program, as well as the number of toxicology

Comprehensive LC/MS Analysis of Illicit and Pain Management Drugs, Including Their Metabolites, in Urine

Comprehensive LC/MS Analysis of Illicit and Pain Management Drugs, Including Their Metabolites, in Urine Application Note Authors Peter JW Stone and Kevin McCann Agilent Technologies, Inc. Santa Clara,

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Important Notes: Last Updated: May 11, 2015 Pharmacists must submit a claim on PharmaNet at the time of purchase to enable coverage.

Harmful Interactions: Mixing Alcohol with Medicines

Harmful Interactions: Mixing Alcohol with Medicines May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. May cause DROWSINESS. ALCOHOL may intensify

PROBLEM: PSYCHOSIS GOALS APPROACHES. Name: MR #: 2009 pacific point consultants 04/09

PROBLEM: PSYCHOSIS GOALS APPROACHES Behavior (only one is required to be monitored, per Title XXII): Either: A. new admission: currently assessing for behaviors. 1. 2. Atypical psychosis Bipolar, mania

Substance Abuse Prevention and Treatment Agency 2012 Community Profile

Substance Abuse Prevention and Treatment Agency 2012 Community Profile Nevada Division of Mental Health and Developmental Services Department of Health and Human Services Brian Sandoval, Governor Michael

Psychotropic Medication Reference Chart

Psychotropic Medication Reference Chart Appendix 4.14 This chart is not an all-inclusive list of medications. If you have a question regarding the classification of a medication you may consult websites

Harmful Interactions: Mixing Alcohol with Medicines

Harmful Interactions: Mixing Alcohol with Medicines. ct. ESS effe SIN this ar ROW nsify a c se D ay inte perating m cau o May OHOL when hinery. ALC CARE us mac USE angero or d U.S. Department of Health

Harmful Interactions

May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. Harmful Interactions mixing alcohol with medicines May cause DROWSINESS. ALCOHOL may intensify

FLORIDA DEPARTMENT OF LAW ENFORCEMENT SEPTEMBER 2013. 2012 Report

FLORIDA DEPARTMENT OF LAW ENFORCEMENT SEPTEMBER 2013 2012 Report Data Collection The Office of Vital Statistics reported more than 178,000 deaths occurred in Florida during 2012. Of these, the medical

HEADACHE QUESTIONNAIRE

Chicago Dizziness and Hearing 645 N. Michigan, Suite 410 Chicago, Illinois, 60611 312-274-0197 NAME: SEND REPORT(S) TO: AGE: Today's Date: Social Sec # HOME Phone: WORK Phone: PHARMACY Phone: Email address

SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2010) Substance Use Disorders E. 2

SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2010) Substance Use Disorders E. 2 *LIFETIME ALCOHOL ABUSE* IF DEFINITE PERIOD: Let me ask you a few more questions about (TIME WHEN DRINKING THE MOST OR HAD PROBLEMS).

TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10

AMBO PROJECT: ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10 Belinda Lloyd ambo project: Alcohol and Drug Related Ambulance

Utility of Oral Fluid in Compliance Monitoring of Opioid Medications

Pain Physician 2014; 17:63-70 ISSN 1533-3159 Prospective Evaluation Utility of Oral Fluid in Compliance Monitoring of Opioid Medications Till Conermann, MD, Ankur R. Gosalia, MD, Abraham Jack Kabazie,

Harmful Interactions. mixing alcohol with medicines

Harmful Interactions mixing alcohol with medicines May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. Harmful interactions You ve probably seen

Emit Drugs of Abuse Urine Assays Cross-Reactivity List. Answers for life.

Emit Drugs of Abuse Urine Assays Cross-Reactivity List Answers for life. Contents Emit II Plus Amphetamines...4 Emit II Plus Barbiturate...8 Emit II Plus Benzodiazepine... 12 Emit II Plus Cannabinoid...

POPULAR DEPRESSION MEDICATIONS

Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant

Medication Side Effects:

Medication Side Effects: Staying Healthy While on Psychotropic Medications Megan Maroney PharmD, BCPP Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers the State University of New Jersey

MVP s Medicare Stars Ratings: High Risk Medications

MVP s Medicare Stars Ratings: High Risk Medications The Center for Medicare and Medicaid Services (CMS) uses the Star Rating System to evaluate Medicare Advantage health plans as well as their networks

Concurrent substance use and mental health disorders An information guide

Concurrent substance use and mental health disorders An information guide W.J. Wayne Skinner, MSW, RSW; Caroline P. O Grady, RN, MN, PhD Christina Bartha, MSW, CSW; Carol Parker, MSW, CSW i Concurrent

Urine drug screens. Screening Methods

Screening Methods Urine drug screens Urine drug screens are generally performed using either immunoassays or gas chromatography-mass spectrometry (GC-MS). 2 Immunoassay UDS contain specific antibodies

Clinical Drug Screening and/or Drug Testing

Manual: Policy Title: Reimbursement Policy Clinical Drug Screening and/or Drug Testing Section: Laboratory & Pathology Subsection: None Date of Origin: 10/26/2011 Policy Number: RPM016 Last Updated: 1/8/2016

MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D.

MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D. BIPOLAR AFFECTIVE DISORDER (BAD) General Assessment is challenging Input important Change in level of functioning

Psychotropic Medication

Page 1 T I P S F O R P R A C T I C E Psychotropic Medication Psychotropic medications are symptomatic medications that affect attention, emotions, or behaviors. Communication between the physician, NDHHS

Frequently Asked Questions about Anti-Seizure Medicine

Frequently Asked Questions about Anti-Seizure Medicine Questions in this guide: 1. How can I get refills? [MUSC patients only] 2. What should I do if I forget a dose? 3. Should I bring my medicine to my

West Virginia Department of Health and Human Resources Bureau for Public Health Office of Emergency Medical Services

OEMSI==o..-::::::- 9 ---- ~ West Virginia Controlled Substance Policy Statement This policy establishes the standard for the management of Controlled Substances by WV EMS agencies in accordance with Federal

New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine

New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept

Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)

Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently

2013 Annual Toxicology Report

213 Annual Toxicology Report Department of Justice Forensic Science Division Toxicology Department 2679 Palmer Street Missoula, MT 5988 DOJTOX@mt.gov Personnel Phil Kinsey Scott Larson Scott Schlueter

Drugs of Abuse CRL PROVIDES SOLUTIONS FOR THE FUTURE

s of Abuse CRL PROVIDES SOLUTIONS FOR THE FUTURE Excellence in Quality and Service Clinical Reference Laboratory s mission is to offer clients a competitive advantage through a unique combination of quality

How To Understand The Health Effects Of Prescription Drugs

Miami-Dade, Broward and Palm Beach Counties, Florida Trends of Nonmedical Prescription Drug Misuse in Miami-Dade, Broward, Palm Beach Counties, and the State of Florida: 2010 James N. Hall 1 ABSTRACT The

Collection Instructions for ARUP Drug Screen Kit #49204

Collection Instructions for ARUP Drug Screen Kit #49204 Manufacturer Purpose of Kit / Reagent (tests) Kit / Reagent Contents (list components) Other Supplies Needed ARUP Laboratories For Point of Collection

Objectives. The use of Psychotropics in Children

Objectives The use of Psychotropics in Children Ashley E. Little, Pharm.D. Psychopharmacology Resident Nova Southeastern University College of Pharmacy Dade County Pharmacy Association To understand current

Update on Drug Impaired Driving. WTSC Impaired Driver Conference SeaTac, December 2006

Update on Drug Impaired Driving WTSC Impaired Driver Conference SeaTac, December 2006 12/4/2007 Alcohol, Drugs and Driving Household Survey, 2004 (prior year) Any Illicit Drug Use 19.9 Million 8.3% Marijuana

Clinic Reference Guide

Clinic Reference Guide 2010 Alliance Toxicology LLC PO Box 5000, PMB 190 Rancho Santa Fe, CA 92067 AllianceToxicologyLLCprovidesclinicaldrugtestingservicesforphysicians.Our companyprovidesacomprehensivedrugtestingpanelwhichincludesover40

Objectives. Depression and Anxiety: Latest in treatment recommendations. At the conclusion of this presentation the attendee will be able to:

Depression and Anxiety: Latest in treatment recommendations Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC President, Fitzgerald Health Education Associates, Inc., North Andover, MA Family

Frequently Asked Questions: HB 341 Mandatory OARRS Registration and Requests

Frequently Asked Questions: HB 341 Mandatory OARRS Registration and Requests Q1) What is OARRS? Updated 12-18-2014 OARRS stands for the Ohio Automated Rx Reporting System. Established in 2006, OARRS is

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

Guidance for Travellers to Thailand under Treatment Carrying Personal Medications Containing Narcotic Drugs/Psychotropic Substances into/out of Thailand This guidance issued by the Narcotics Control Division,

lite 2014 Genelex Corporation. All Rights Reserved.

lite The following tables show commonly prescribed medications with drug exposure likely to be impacted by the patient s phenotype indicated. These tables are not all inclusive and do not account for concomitant

CNS Depressants. GABA Receptor Complex. Barbiturates 2/11/2014. Cause Dose-Dependent CNS Depression

CNS Depressants Includes alcohol & a wide variety of drugs used as sedatives, hypnotics (sleeping pills), anti-anxiety tranquilizers, anesthetics, and anti-convulsants Cause Dose-Dependent CNS Depression

Prescription Medications &Weight Gain What You Need to Know

Prescription Medications & Weight Gain What You Need to Know by Ted Kyle, RPh, MBA, and Bonnie Kuehl, PhD How can I be gaining weight? I m eating smarter, I m walking more. What am I doing wrong? You might

Indiana State Department of Toxicology 2012 Annual Report

Indiana State Department of Toxicology 2012 Annual Report Pictured on the cover is the State of Indiana Forensic and Health Sciences Laboratories facility housing the Indiana State Department of Toxicology.

What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs?

What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs? 2 CONTENT SUMMARY Drug diversion is the illegal distribution or abuse of prescription drugs or their use for unintended purposes.

Family Guide. West S p ring s Hos p ital

Family Guide West S p ring s Hos p ital Dear Family Members, We are appreciative of the opportunity to take care of your loved one at this difficult time. Please know that our objective is to provide

DRUG DRIVING OFFENCES

DRUG DRIVING OFFENCES Taking drug can affect body and mind coordination that can significantly impair the ability to drive a motor vehicle. Road Traffic Ordinance (Cap 374) was amended in 2011 in order

Opiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern

LC-MS for Pain Management Support. Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories

LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic

PROFILE -V MEDTOXScan Drugs of Abuse Test System INSERT

PROFILE -V MEDTOXScan Drugs of Abuse Test System INSERT 1. INTENDED USE The PROFILE -V MEDTOXScan Drugs of Abuse Test System consists of the PROFILE -V MEDTOXScan Test Devices and the MEDTOXScan Reader.

Measuring Generic Efficiency in Part D

Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c

LC-MS for Pain Management Support

LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic

Pharmacological Management of Dementia

Pharmacological Management of Dementia Christopher Sullivan Lead Clinical Pharmacist South and West Devon Devon Partnership Trust Overview Management of cognitive symptoms Management of non-cognitive symptoms

A few general principles regarding medications are important to consider before initiating therapy in individuals diagnosed with a dementia

MEDICATIONS USED FOR THE MANAGEMENT OF DEMENTIA AND RELATED BEHAVIORIAL COMPLICATIONS* R.Ron Finley, B.S Pharm, R.Ph,CGP, Aimee Loucks, Pharm. D., Gil D. Rabinovici, M.D The following is intended to be